Article 07 May 2024 PTAB Issues Final Written Decisions Finding Claims Of Recombinant Lentiviral Vector Patents Valid United States IP
Article 03 Apr 2024 FDA Approves First Gene Therapy To Treat Children With Metachromatic Leukodystrophy United States Healthcare
Article 05 Mar 2024 FDA Approves First Cellular Therapy For Treatment Of Unresectable Or Metastatic Melanoma United States Healthcare
Article 26 Jan 2024 PTAB Issues Final Written Decisions Finding Claims Of Aflibercept-Related Patents Invalid United States IP
Article 06 Oct 2023 Biogen Announces FDA Approval Of TOFIDENCE, A Tocilizumab Biosimilar Referencing ACTEMRA United States Healthcare
Article 04 Sep 2023 PTAB Issues Final Written Decisions Finding Claims Of Tocilizumab-related Patents Invalid United States IP
Article 26 Jun 2023 Samsung Bioepis Files Four IPR Petitions On Alexion Eculizumab Patents And One IPR Petition On A Janssen Ustekinumab Patent United States IP
Article 19 Apr 2023 Accord BioPharma Announces The Acceptance Of BLA For HLX02 (a Proposed Trastuzumab Biosimilar) By FDA United States Healthcare